Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Abilify

ABILIFY 5 mg tablets ABILIFY 10 mg tablets ABILIFY 15 mg tablets ABILIFY 30 mg tablets · Abschnitt 4.8 · PDF-Seite 9–10

HOS-217786 · Präparat HOS-216111

9  Common Uncommon Not known Endocrine Hyperprolactinaemia Diabetic hyperosmolar coma disorders Blood prolactin Diabetic ketoacidosis decreased Metabolism and Diabetes mellitus Hyperglycaemia Hyponatremia nutrition disorders Anorexia Psychiatric Insomnia Depression Suicide attempt, suicidal ideation disorders Anxiety Hypersexuality and completed suicide (see Restlessness section 4.4) Gambling disorder Impulse-control disorder Binge eating Compulsive shopping Poriomania Aggression Agitation Nervousness Nervous system Akathisia Tardive dyskinesia Neuroleptic Malignant Syndrome disorders Extrapyramidal Dystonia Grand mal convulsion disorder Restless legs Serotonin syndrome Tremor syndrome Speech disorder Headache Sedation Somnolence Dizziness Eye disorders Vision blurred Diplopia Oculogyric crisis Photophobia Cardiac disorders Tachycardia Sudden death unexplained Torsades de pointes Ventricular arrhythmia Cardiac arrest Bradycardia Vascular disorders Orthostatic Venous thromboembolism hypotension (including pulmonary embolism and deep vein thrombosis) Hypertension Syncope Respiratory, Hiccups Aspiration pneumonia thoracic and Laryngospasm mediastinal Oropharyngeal spasm disorders Gastrointestinal Constipation Pancreatitis disorders Dyspepsia Dysphagia Nausea Diarrhoea Salivary Abdominal discomfort hypersecretion Stomach discomfort Vomiting Hepatobiliary Hepatic failure disorders Hepatitis Jaundice Skin and Rash subcutaneous tissue Photosensitivity reaction disorders Alopecia Hyperhidrosis Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.